To access this element change to forms mode OFF
Grant Award View - GA171275
The CANnabinoids for CANcer Therapy (CANCAN) Trial
GA ID:
GA171275
Agency:
Department of Health and Aged Care
Approval Date:
27-Apr-2021
Publish Date:
15-Jun-2021
Category:
Health and Medical Research
Grant Term:
1-Jun-2021 to 31-May-2026
Value (AUD):
$1,486,715.40
(GST inclusive where applicable)
One-off/Ad hoc:
No
Aggregate Grant Award:
No
PBS Program Name:
DoHAC 20/21 1.1 Health Policy Research and Analysis
Grant Program:
2020_MRFF_EPCDR_Medicinal_Cannabis_Clinical_Trials
Grant Activity:
The CANnabinoids for CANcer Therapy (CANCAN) Trial
Purpose:
Medicinal cannabis has been investigated for the management of cancer therapy symptoms. However, there is insufficient evidence to guide its use in clinical practice. The CANCAN trial will address this gap by exploring the use of personalised CBD/THC dosing to prevent common and impactful symptoms of treatment in advanced cancer.
GO ID:
GO Title:
MRFF – Emerging Priorities and Consumer Driven Research – 2020 Medicinal Cannabis Clinical Trials Grant Opportunity
Internal Reference ID:
MRF2006584
Selection Process:
Targeted or Restricted Competitive
Confidentiality - Contract:
Yes
Confidentiality Reason(s) - Contract:
Privacy Act 1988
Intellectual property
Intellectual property
Confidentiality - Outputs:
Yes
Confidentiality Reason(s) - Outputs:
Intellectual property
Grant Recipient Details
Recipient Name:
University of Adelaide
Recipient ABN:
61 249 878 937
Grant Recipient Location
Suburb:
Adelaide
Town/City:
Adelaide
Postcode:
5000
State/Territory:
SA
Country:
AUSTRALIA
Grant Delivery Location
State/Territory:
SA
Postcode:
Country:
AUSTRALIA